Scholarlink

<p> A low cost and rapid electrochemical immunosensor for direct screening of L-phenylalanine (L-Phe) using square wave voltammetry (SWV)&#xa0;is presented. Fern-like gold nanostructures were electro-deposited onto a screen-printed electrode (SPE) using chronoamperometry (CA), to enhance sensitivity and surface area. A novel light-driven surface functionalisation process was used to decorate the gold nanostructured SPE with target-specific antibody fragments and develop the L-Phe-specific immunosensor. The selectivity of the sensor was confirmed against tyrosine, tryptophan and D-phenylalanine, thus indicating the sensor’s potential for use at points of care (POC) without interference from structurally related biomolecules. The sensor demonstrated high sensitivity across the full clinical range (120 µM-1200 µM) and excellent linearity within the concentration range 1 µM to 2000 µM (R²= 0.99, LOD = 0.3 µM, LOQ = 1 µM). Quantification of L-Phe in human blood dry spots (DBS) by the new sensor and SWV were in excellent agreement with mass spectroscopy (MS) measurements by 2 independent pathology labs. The sensor was successfully integrated with an ultra-compact potentiostat in a Lab-on-a-Phone assembly for L-Phe screening in DBS, thus demonstrating its potential for use at POC and at home by phenylketonuria (PKU) patients in both remote and rural areas. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ultra-sensitive nanostructured electrochemical immunosensor for selective monitoring of L-phenylalanine in phenylketonuria patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月23日

查看全文
  • Rebecca L. Houston,
  • Eric C. Y. Law,
  • Emad L. Izake

摘要

A low cost and rapid electrochemical immunosensor for direct screening of L-phenylalanine (L-Phe) using square wave voltammetry (SWV) is presented. Fern-like gold nanostructures were electro-deposited onto a screen-printed electrode (SPE) using chronoamperometry (CA), to enhance sensitivity and surface area. A novel light-driven surface functionalisation process was used to decorate the gold nanostructured SPE with target-specific antibody fragments and develop the L-Phe-specific immunosensor. The selectivity of the sensor was confirmed against tyrosine, tryptophan and D-phenylalanine, thus indicating the sensor’s potential for use at points of care (POC) without interference from structurally related biomolecules. The sensor demonstrated high sensitivity across the full clinical range (120 µM-1200 µM) and excellent linearity within the concentration range 1 µM to 2000 µM (R²= 0.99, LOD = 0.3 µM, LOQ = 1 µM). Quantification of L-Phe in human blood dry spots (DBS) by the new sensor and SWV were in excellent agreement with mass spectroscopy (MS) measurements by 2 independent pathology labs. The sensor was successfully integrated with an ultra-compact potentiostat in a Lab-on-a-Phone assembly for L-Phe screening in DBS, thus demonstrating its potential for use at POC and at home by phenylketonuria (PKU) patients in both remote and rural areas.